Xenleta 150 mg concentrate for solution for infusion

Licence status
Authorised: 27/07/2020
Active substances
Lefamulin
Dosage Form
Concentrate and solvent for solution for infusion
Licence number
EU/1/20/1457/001
Licence holder
Nabriva Therapeutics Ireland Designated Activity Company

Product documents

Licence information

ATC code
J01XX Other antibacterials, J01XX12 lefamulin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
27/07/2020